Get a weekly summary of what Congress did, delivered every Sunday.

  • About
  • How Congress Works
  • Quiz
  • Congress Wrapped
  • Support Us
  • Roadmap
  • Health
  • Privacy Policy
  • Terms of Service
WhiteHouse.wiki•SCOTUS.wiki
Congress.wiki Alpha

This is not an official government website.

© 2026 PLEJ LC. All rights reserved.

Map
Live
Schedule
Daily Record
Special Rules
Subpoenas
Foreign Influence
Agencies
Regulations
Office Spending
US Code
Open search

Federal Regulations

How Congress's laws become real-world rules. Browse regulatory dockets from Regulations.gov — tracking rulemaking activity, public comment periods, and the agencies turning legislation into policy.

Dockets
6,352
Regulations.gov

Showing 30 of 6,352 dockets

Nonrulemaking
FDA
Open for Comments

FDA-2025-E-3626

Patent Term Extension Application for ENFLONSIA (clesrovimab-cfor) Patent No. 9,963,500

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
ED
Open for Comments

ED-2026-SCC-1057

Annual Report of Children in State Agency and Locally Operated Institutions for Neglected and Delinquent Children

3 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-3074

Patent Term Extension Application for EMRELIS (telisotuzumab vedotin-tllv), Patent No. 10,603,389

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA

FDA-2001-N-0106

Safety & Effectiveness of New Drug & Biological Products in Pediatric Patients

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-3073

Patent Term Extension Application for EMRELIS (telisotuzumab vedotin-tllv), Patent No. 10,383,948

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA

FDA-2001-N-0173

Rapid Response Surveys; Agency Information Collection Activities

3 docsNo comments
Nonrulemaking
FDA

FDA-2001-N-0227

Format & Content Requirements for OTC Drug Product Labeling

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0372

Patent Term Application for ZIIHERA® (zanidatamab-hrii), Patent No. 10,000,576

5 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0872

Patent Term Application for VYLOY (zolbetuximab-clzb), Patent No. 12,059,464

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0871

Patent Term Application for VYLOY (zolbetuximab-clzb), Patent No. 11,395,852

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA

FDA-2025-H-5930

DAB Civil Money Penalty; Broadway Grocery Corp d/b/a Broadway Grocery Corp; CLOSED 4/3/2026

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0870

Patent Term Application for VYLOY (zolbetuximab-clzb), Patent No. 10,738,108

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0869

Patent Term Application for VYLOY (zolbetuximab-clzb), Patent No. 10,174,104

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA

FDA-2026-H-3165

DAB Civil Money Penalty; SJH Retail LLC d/b/a Vape-Loco

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0868

Patent Term Application for VYLOY (zolbetuximab-clzb), Patent No. 10,137,195

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0867

Patent Term Application for VYLOY (zolbetuximab-clzb), Patent No. 10,022,444

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
DOD

DOD-2026-OS-0463

Privacy Act of 1974; System of Records (Uniformed Services Human Resources Information System, DMDC 01)

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0866

Patent Term Application for VYLOY (zolbetuximab-clzb), Patent No. 10,017,564

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0865

Patent Term Application for VYLOY® (zolbetuximab-clzb), Patent No. 9,751,934

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
NHTSA
Open for Comments

NHTSA-2024-0072

Novel Human-Machine Interface (HMI) Designs

1 docNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0864

Patent Term Application for VYLOY (zolbetuximab-clzb), Patent No. 9,499,609

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0863

Patent Term Application for VYLOY (zolbetuximab-clzb), Patent No. 9,212,228

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0845

Patent Term Application for VYLOY (zolbetuximab-clzb), Patent No. 10,813,996

6 docsNo comments
Comments due Jun 3, 2026
Rulemaking
FAA

FAA-2026-1024

Amend Class D/E2, Binghamton, NY (BGM) (26-AEA-2)

2 docsNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2026-N-2740

Agency Information Collection Activities; Proposed Collection; Comment Request; Customer/Partner Customer Service Satisfaction Surveys

1 docNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA

FDA-2026-H-2151

DAB Civil Money Penalty; Speedway LLC, d/b/a Speedway 5018; CLOSED 4/2/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2026-H-1992

DAB Civil Money Penalty; Adya Two LLC, d/b/a Jerome Fuel Mart / Marathon; CLOSED 4/2/2026

1 docNo comments
Nonrulemaking
NRC
Open for Comments

NRC-2026-1618

Arizona Public Service Company; Palo Verde Nuclear Generating Station, Units 1, 2, and 3, Consideration of Approval of Transfer of License

1 docNo comments
Comments due May 5, 2026
Nonrulemaking
FDA

FDA-2026-H-2158

DAB Civil Money Penalty; A & A Tobacco, LLC., d/b/a 6th Street Smoke Shop & Vape; CLOSED 4/2/2026

1 docNo comments
Nonrulemaking
NRC

NRC-2026-0298

NextEra Energy Duane Arnold, LLC; Duane Arnold Energy Center; Consideration of Approval of Transfer of Licenses and Conforming Amendment

2 docs1 comment
  • Previous
  • Page 99 of 212
  • Next